Literature DB >> 29030450

Effect of concussion and blast exposure on symptoms after military deployment.

Jack W Tsao1, Lauren A Stentz2, Minoo Rouhanian2, Robin S Howard2, Briana N Perry2, F Jay Haran2, Paul F Pasquina2, Mikias Wolde2, Carolyn E Taylor2, Radhames Lizardo2, Scott Liu2, Eusebio Flores2, Alia H Creason2, Katalina Sher2.   

Abstract

OBJECTIVE: To examine whether blast exposure alone and blast-associated concussion result in similar neurologic and mental health symptoms.
METHODS: A 14-item questionnaire was administered to male US Marines on their return from deployment in Iraq and/or Afghanistan.
RESULTS: A total of 2,612 Marines (median age 22 years) completed the survey. Of those, 2,320 (88.9%) reported exposure to ≥1 blast during their current and/or prior deployments. In addition, 1,022 (39.1%) reported ≥1 concussion during the current deployment, and 731 (28.0%) had experienced at least 1 prior lifetime concussion. Marines were more likely to have sustained a concussion during the current deployment if they had a history of 1 (odds ratio [OR] 1.5, 95% confidence interval [CI] 1.2-2.0) or ≥1 (OR 2.3, 95% CI 1.7-3.0) prior concussion. The most common symptoms were trouble sleeping (38.4%), irritability (37.9%), tinnitus (33.8%), and headaches (33.3%). Compared to those experiencing blast exposure without injury, Marines either experiencing a concussion during the current deployment or being moved or injured by a blast had an increased risk of postinjury symptoms.
CONCLUSIONS: There appears to be a continuum of increasing total symptoms from no exposure to blast exposure plus both current deployment concussion and past concussion. Concussion had a greater influence than blast exposure alone on the presence of postdeployment symptoms. A high blast injury score can be used to triage those exposed to explosive blasts for evaluation.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 29030450     DOI: 10.1212/WNL.0000000000004616

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

2.  Auditory and Cognitive Behavioral Performance Deficits and Symptom Reporting in Postconcussion Syndrome Following Mild Traumatic Brain Injury.

Authors:  Kathy R Vander Werff; Brian Rieger
Journal:  J Speech Lang Hear Res       Date:  2019-07-01       Impact factor: 2.297

3.  Alterations in the Topology of Functional Connectomes Are Associated with Post-Traumatic Stress Disorder and Blast-Related Mild Traumatic Brain Injury in Combat Veterans.

Authors:  Jared A Rowland; Jennifer R Stapleton-Kotloski; Sarah L Martindale; Emily E Rogers; Anna S Ord; Dwayne W Godwin; Katherine H Taber
Journal:  J Neurotrauma       Date:  2021-11-15       Impact factor: 5.269

4.  Occupation and Risk of Traumatic Brain Injury in the Millennium Cohort Study.

Authors:  Kalyn C Jannace; Lisa Pompeii; David Gimeno Ruiz de Porras; William Brett Perkison; Jose-Miguel Yamal; Daniel W Trone; Rudolph P Rull
Journal:  Mil Med       Date:  2022-02-27       Impact factor: 1.563

Review 5.  Traumatic Brain Injury and Posttraumatic Stress Disorder: Comorbid Consequences of War.

Authors:  John Ni Dieter; Scot D Engel
Journal:  Neurosci Insights       Date:  2019-12-31

Review 6.  Military TBI-What civilian primary care providers should know.

Authors:  Megan A Lindberg; Stephanie S Sloley; Brian J Ivins; Donald W Marion; Elisabeth M Moy Martin
Journal:  J Family Med Prim Care       Date:  2021-12-27

7.  Sequelae of Blast Events in Iraq and Afghanistan War Veterans using the Salisbury Blast Interview: A CENC Study.

Authors:  Jared A Rowland; Sarah L Martindale; Kayla M Spengler; Robert D Shura; Katherine H Taber
Journal:  Brain Inj       Date:  2020-02-25       Impact factor: 2.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.